ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Berlin, BE, DEU:

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...

Active, not recruiting
Breast Cancer
Procedure: Surgical resection of breast tumor
Drug: ARV-471

Phase 2

Arvinas
Arvinas

Berlin, Germany and 48 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Berlin, Germany and 226 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Berlin, Germany and 114 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Berlin, Germany and 324 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 147 other locations

This is a single-arm, open-label phase IV study of patients with advanced HR+/HER2- breast cancer who are treated first line with r...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Ribociclib

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 51 other locations

PREcoopERA is a randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safe...

Enrolling
Breast Cancer
Drug: Anastrozole
Drug: Giredestrant

Phase 2

ETOP IBCSG Partners Foundation

Berlin, Germany and 43 other locations

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy a...

Active, not recruiting
HER2-Positive Primary Breast Cancer
Residual Invasive Breast Cancer
Drug: DS-8201a
Drug: T-DM1

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Berlin, Germany and 482 other locations

to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Anastrozole
Drug: Exemestane

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 692 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Nab-Paclitaxel
Drug: Trastuzumab deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 293 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems